Clinical trial
Clinical Outcomes of Stroke in MalIgnanCy (COSMIC)
NCT07895173 is registered in ClinicalTrials.gov with University of L'Aquila as lead sponsor.
Follow this trial by email Email me the PDF
Summary
Not yet recruiting, started October 2026. Observational study, 1,000 participants (estimated). Lead sponsor University of L'Aquila. Primary measure: Recurrent stroke. 13 linked papers (newest 2023).
How it compares
71 similar trials: same condition (Hemorrhagic Stroke) and phase
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Outcomes of Stroke in MalIgnanCy (COSMIC)
- Lead sponsor
- University of L'Aquila
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- October 31, 2026
- Completion date
- January 31, 2029
- Enrollment
- 1,000 (estimated)
- Sites
- Not reported
Conditions
MeSH condition names; the registry's own terms follow.
Hemorrhagic Stroke, Ischemic Stroke, Neoplasms, Stroke
Registry terms: malignancies multiple
Who could take part, where it ran, who ran it
As filed in ClinicalTrials.gov.
- Sex
- All
- Minimum age
- 18 Years
- Healthy volunteers
- No
- Study type
- Observational
- Lead sponsor
- University of L'Aquila
Primary endpoints
Registered primary outcome measures; 1 primary.
| Measure | Time frame |
|---|---|
| Recurrent stroke | 1 year |
Show registry wordingAny recurrent stroke within 1 year, defined as recurrent ischemic stroke and/or new spontaneous non-traumatic ICH occurring after the index event. Hemorrhagic transformation of an ischemic infarct is not counted as recurrent ICH. | |
Papers
PubMed papers this trial cites; 13 papers, results papers first, then newest first.
+8 more papers
Lead sponsor's other trials
University of L'Aquila, most recent start first.
+43 more trials See the organization page
Similar trials
Same condition (Hemorrhagic Stroke) and phase, most recent start first.
+66 more trials See the condition page